Clinical Trial Update: Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing Letermovir to Valaciclovir for prenatal treatment of congenital cytomegalovirus infection is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Cytomegalovirus Infection

Drugs mentioned

• Letermovir (letermovir)
• Valaciclovir (valaciclovir)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Pregnant Women, CMV Infected Fetuses | Phase 3 | Status: RECRUITING